Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$119.39 USD

119.39
6,741,790

+1.50 (1.27%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $119.40 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

Company News for Oct 19, 2023

Companies In The News Are: PG, ABT, STT, USB.

Geopolitical Conflicts in Middle-East in Focus

Geopolitical Conflicts in Middle-East in Focus.

Abbott (ABT) Q3 Earnings and Revenues Surpass, Margins Dip

Abbott (ABT) reports solid underlying base business performance in the third quarter of 2023.

Pre-Markets in Red on Mid-East Concerns, Q3 Earnings in Focus

U.S. stock futures are trading lower as the geopolitical conflicts between Israel and Palestine-based terrorist group Hamas heightened.

Abbott (ABT) Reports Q3 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Abbott (ABT) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Abbott (ABT) Beats Q3 Earnings and Revenue Estimates

Abbott (ABT) delivered earnings and revenue surprises of 3.64% and 3.60%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Intuitive Surgical (ISRG) to Post Q3 Earnings: What's in Store?

Intuitive Surgical's (ISRG) third-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs might have hurt margins.

Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?

Smart Beta ETF report for NOBL

Should You Buy Abbott (ABT) Ahead of Earnings?

Abbott (ABT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

(ABT) Gains As Market Dips: What You Should Know

Abbott (ABT) closed at $90.87 in the latest trading session, marking a +0.75% move from the prior day.

Will Abbott (ABT) Beat Estimates Again in Its Next Earnings Report?

Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

What's in Store for Abbott Laboratories (ABT) in Q3 Earnings?

Abbott Laboratories' (ABT) third-quarter 2023 results are likely to reflect solid underlying base business organic sales growth.

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

HLN vs. ABT: Which Stock Is the Better Value Option?

HLN vs. ABT: Which Stock Is the Better Value Option?

(ABT) Ascends While Market Falls: Some Facts to Note

Abbott (ABT) closed at $96.20 in the latest trading session, marking a +0.58% move from the prior day.

The Zacks Analyst Blog Highlights Abbott Laboratories, Koninklijke Philips and Smith & Nephew

Abbott Laboratories, Koninklijke Philips and Smith & Nephew are included in this Analyst Blog.

Indrajit Bandyopadhyay headshot

3 Medical Product Stocks With Solid Dividend Yield: ABT & Others

Here we pick three stocks, Abbott Laboratories (ABT), Koninklijke Philips (PHG) and Smith & Nephew SNATS (SNN) from the Medical - Products industry, with a solid five-year dividend growth history.

Abbott (ABT) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Abbott (ABT) closed at $96.85, marking a -1.29% move from the previous day.

Abbott (ABT) Rides on Nutrition Recovery Amid Low Testing Sales

Abbott's (ABT) Nutrition business has started showing signs of recovery since the beginning of 2023.

After Plunging -8.5% in 4 Weeks, Here's Why the Trend Might Reverse for Abbott (ABT)

The heavy selling pressure might have exhausted for Abbott (ABT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

The Zacks Analyst Blog Highlights Alphabet, Exxon Mobil, Merck, Abbott Laboratories and NextEra Energy

Alphabet, Exxon Mobil, Merck, Abbott Laboratories and NextEra Energy are part of the Zacks top Analyst Blog.

Abbott (ABT) Stock Sinks As Market Gains: What You Should Know

Abbott (ABT) closed at $95.53 in the latest trading session, marking a -0.73% move from the prior day.

Mark Vickery headshot

Top Stock Reports for Alphabet, Exxon Mobil & Merck

Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Exxon Mobil Corp. (XOM) and Merck & Co., Inc. (MRK).

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.